CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME - USD ($) |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Statement of Operations [Abstract] | ||||
| Revenues | $ 16,390,944 | $ 16,176,339 | $ 35,898,430 | $ 31,544,203 |
| Cost of Revenues | 8,955,702 | 9,287,146 | 19,888,761 | 17,933,997 |
| Gross Profit | 7,435,242 | 6,889,193 | 16,009,669 | 13,610,206 |
| Product Royalty Income | 135,115 | 48,306 | 507,934 | 133,604 |
| Operating Expenses | ||||
| Salaries and wages | 2,176,254 | 1,846,237 | 4,324,880 | 3,703,617 |
| Commissions and consulting expenses | 219,661 | 187,434 | 455,454 | 345,156 |
| Professional fees | 212,003 | 155,345 | 502,495 | 515,396 |
| Advertising and marketing | 1,428,833 | 1,152,207 | 2,490,029 | 2,044,264 |
| Office lease and expenses | 199,053 | 176,120 | 439,768 | 345,296 |
| Research and development costs | 664,839 | 616,795 | 1,462,187 | 1,281,285 |
| Bad debt expense (recovery) | (80,543) | (31,155) | 49,539 | (94,659) |
| General and administrative expenses | 1,313,482 | 1,101,992 | 2,523,715 | 2,114,641 |
| Depreciation | 284,244 | 332,606 | 798,860 | 659,614 |
| Total operating expenses | 6,417,826 | 5,537,581 | 13,046,927 | 10,914,610 |
| Income from Operations | 1,152,531 | 1,399,918 | 3,470,676 | 2,829,200 |
| Other Income | ||||
| Interest and other income, net | 76,268 | 117,737 | 150,764 | 199,884 |
| Total other Income | 76,268 | 117,737 | 150,764 | 199,884 |
| Income Before Provision for Income Taxes | 1,228,799 | 1,517,655 | 3,621,440 | 3,029,084 |
| Provision for Income taxes | 319,810 | 378,921 | 941,757 | 769,226 |
| Net Income Available to Common Shareholders | $ 908,989 | $ 1,138,734 | $ 2,679,683 | $ 2,259,858 |
| Net Income per Common Share | ||||
| Basic | $ 0.15 | $ 0.18 | $ 0.43 | $ 0.36 |
| Diluted | $ 0.14 | $ 0.18 | $ 0.41 | $ 0.35 |
| Weighted Average Number of Common Shares Outstanding | ||||
| Basic | 6,229,656 | 6,217,550 | 6,232,899 | 6,217,550 |
| Diluted | 6,464,988 | 6,475,942 | 6,468,231 | 6,475,942 |
| Comprehensive Income | ||||
| Net Income | $ 908,989 | $ 1,138,734 | $ 2,679,683 | $ 2,259,858 |
| Other comprehensive income, net of $0 and $0 deferred income taxes in 2026 and 2025 | ||||
| Foreign currency translation | 160,119 | 136,096 | 46,087 | 202,476 |
| Total Comprehensive Income | $ 1,069,108 | $ 1,274,830 | $ 2,725,770 | $ 2,462,334 |
| X | ||||||||||
- Definition Commissions and consulting expenses No definition available.
|
| X | ||||||||||
- Definition Other Comprehensive Income Net Of Deferred Income Taxes [Abstract] No definition available.
|
| X | ||||||||||
- Definition Represents about product royalty income. No definition available.
|
| X | ||||||||||
- Definition Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of interest income (expense) classified as operating. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The total expense recognized in the period for promotion, public relations, and brand or product advertising. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of expense (reversal of expense) for expected credit loss on accounts receivable. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense for salary and wage arising from service rendered by nonofficer employee. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|